BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dinccelik-Aslan M, Gumus-Akay G, Elhan AH, Unal E, Tukun A. Diagnostic and prognostic significance of glypican 5 and glypican 6 gene expression levels in gastric adenocarcinoma. Mol Clin Oncol 2015;3:584-90. [PMID: 26137271 DOI: 10.3892/mco.2015.486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Li N, Gao W, Zhang YF, Ho M. Glypicans as Cancer Therapeutic Targets. Trends Cancer 2018;4:741-54. [PMID: 30352677 DOI: 10.1016/j.trecan.2018.09.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 11.3] [Reference Citation Analysis]
2 Zeng C, Yan R, Yang G, Xiang S, Zhao F. Hedgehog signaling activation required for glypican-6-mediated regulation of invasion, migration, and epithelial-mesenchymal transition of gastric cancer cells. Biosci Rep 2020;40:BSR20193181. [PMID: 32478377 DOI: 10.1042/BSR20193181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fan C, Tu C, Qi P, Guo C, Xiang B, Zhou M, Li X, Wu X, Li X, Li G, Xiong W, Zeng Z. GPC6 Promotes Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma. J Cancer 2019;10:3926-32. [PMID: 31417636 DOI: 10.7150/jca.31345] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
4 Hu B, Xing W, Li F, Huang Z, Zheng W, Ji D, Niu F, Zhu Y, Yang X. Association of glypican-6 polymorphisms with lumbar disk herniation risk in the Han Chinese population. Mol Genet Genomic Med 2019;7:e00747. [PMID: 31111662 DOI: 10.1002/mgg3.747] [Reference Citation Analysis]
5 Al-Saraireh YM, Alshammari FO, Youssef AM, Al-Sarayreh S, Al-Sarayra YM, Aborajooh E, Al-Shuneigat J, Alrawashdeh HM. Screening of Glypican-6 Expression in Benign, Primary and Metastatic Colon Cancers. Clin Med Insights Oncol 2021;15:11795549211036419. [PMID: 34393539 DOI: 10.1177/11795549211036419] [Reference Citation Analysis]
6 De Pasquale V, Pavone LM. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment. Int J Mol Sci 2020;21:E6588. [PMID: 32916872 DOI: 10.3390/ijms21186588] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
7 Cherfils-Vicini J, Iltis C, Cervera L, Pisano S, Croce O, Sadouni N, Győrffy B, Collet R, Renault VM, Rey-Millet M, Leonetti C, Zizza P, Allain F, Ghiringhelli F, Soubeiran N, Shkreli M, Vivier E, Biroccio A, Gilson E. Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2. EMBO J 2019;38:e100012. [PMID: 31000523 DOI: 10.15252/embj.2018100012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
8 Li N, Spetz MR, Ho M. The Role of Glypicans in Cancer Progression and Therapy. J Histochem Cytochem 2020;68:841-62. [PMID: 32623934 DOI: 10.1369/0022155420933709] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
9 Zhao X, Yan H, Yan X, Chen Z, Zhuo R, Mi Y. A Novel Prognostic Four-Gene Signature of Breast Cancer Identified by Integrated Bioinformatics Analysis. Disease Markers 2022;2022:1-17. [DOI: 10.1155/2022/5925982] [Reference Citation Analysis]
10 Zhou F, Shang W, Yu X, Tian J. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment. Med Res Rev. 2018;38:741-767. [PMID: 28621802 DOI: 10.1002/med.21455] [Cited by in Crossref: 87] [Cited by in F6Publishing: 100] [Article Influence: 17.4] [Reference Citation Analysis]
11 Zhao D, Liu S, Sun L, Zhao Z, Liu S, Kuang X, Shu J, Luo B. Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma. Virus Research 2016;220:52-6. [DOI: 10.1016/j.virusres.2016.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]